Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Petros Pharmaceuticals ( (PTPI) ) has issued an announcement.
Petros Pharmaceuticals, Inc. announced that its common stock will be delisted from the Nasdaq Stock Market, effective ten days after the filing of Form 25 with the Securities and Exchange Commission. The stock, which was suspended from Nasdaq trading in May 2025, has been trading on the OTCID Basic Market since July 2025 and will continue to do so without disruption, while the company remains subject to certain reporting obligations.
More about Petros Pharmaceuticals
Average Trading Volume: 328,632
Technical Sentiment Signal: Sell
Current Market Cap: $826.3K
Learn more about PTPI stock on TipRanks’ Stock Analysis page.